SynAir-G

Disrupting Noxious Synergies of Indoor Air Pollutants and their Impact in Childhood Health and Wellbeing, using Advanced Intelligent Multisensing and Green Interventions

Different pollutants such as viruses, bacteria, pollen, or fine dust have – also in interaction (keyword synergies) – effects on our lung health, our immune system, and our mental health. Particularly vulnerable populations including children and people with allergies and/or asthma, and people from low socio-economic backgrounds are affected the most but there are no specific guidelines or interventions for them. The aim of the SynAir-G project is to find out and quantify, which combinations of air pollutants are most harmful to our health and how they affect the body, from mechanisms to real life, by analysing the composition of air pollutants, using the indoor air of schools as an example.

A comprehensive and responsive multi-pollutant monitoring system will be developed, environmentally friendly measures will be promoted, and the knowledge gained will be disseminated to relevant stakeholders in an accessible and implementable form.

For such a system to work reliably under heterogeneous environmental conditions, it is crucial to standardize the functioning of the system components. DIN is responsible for standardization within the project and will therefore conduct research on relevant existing Standards and will help to transfer project results into national, European, or international standardization.

Project website: www.synairg.eu

Further information: www.cordis.europa.eu/project/id/101057271 ; https://www.linkedin.com/company/synair-g

Project duration

09/2022 – 08/2026

Project coordination

ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON (GRC)

Project partners

  • INLECOM GROUP (BEL)
  • INLECOM INNOVATION ASTIKI MI KERDOSKOPIKI ETAIREIA (GRC) (Third-Party)
  • CY.R.I.C. CYPRUS RESEARCH AND INNOVATION CENTER LTD (CYP)
  • DIN DEUTSCHES INSTITUT FUER NORMUNG EV (DEU)
  • GLOBAL ALLERGY AND ASTHMA EUROPEAN NETWORK (GALEN) EV (DEU)
  • UNIVERSITATSKLINIKUM ERLANGEN (DEU)
  • NAAVA GROUP OY (FIN)
  • OULUN YLIOPISTO (FIN)
  • CENTRE HOSPITALIER UNIVERSITAIRE MONTPELLIER (FRA)
  • TEQOYA (FRA)
  • CENTER FOR ALLERGY AND IMMUNOLOGY RESEARCH (GEO)
  • ARISTOTELIO PANEPISTIMIO THESSALONIKIS (GRC)
  • IDRYMA TECHNOLOGIAS KAI EREVNAS (GRC)
  • INLECOM INNOVATION ASTIKI MI KERDOSKOPIKI ETAIREIA (GRC) (Third-Party)
  • PANEPISTIMIO PATRON (GRC)
  • BIO CHECK UP SRL (ITA)
  • CONSIGLIO NAZIONALE DELLE RICERCHE (ITA)
  • EUROPEAN FEDERATION OF ASTHMA & ALLERGY ASSOCIATIONS IDEELL FORENING (SWE)
  • LULEA TEKNISKA UNIVERSITET (SWE)
  • ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE(CHE):
  • SCHWEIZERISCHES FORSCHUNGSINSTITUT FUER HOCHGEBIRGSKLIMA UND MEDIZIN IN DAVOS (CHE)
  • THE UNIVERSITY OF MANCHESTER (GBR)

Project funding

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.

Contact

Mr.
Stefan Kelnberger

Am DIN-Platz
Burggrafenstraße 6
10787 Berlin

Send message to contact  

TOP